March 2015

  • Study reports excellent outcomes among HIV+ kidney transplant recipients

    HIV+ kidney transplant recipients who are not infected with hepatitis C virus (HCV) have similar kidney and patient survival rates as HIV- recipients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that excellent outcomes can be achieved among HIV+ kidney transplant recipients.

  • Rapid testing for gene variants in kidney donors may optimize transplant outcomes

    Kidney transplantation outcomes from deceased African-American donors may improve through rapid testing for apolipoprotein L1 gene (APOL1) renal risk variants at the time of organ recovery, according to a new study led by researchers at Wake Forest Baptist Medical Center.

  • Diabetes drugs may promote heart failure, study finds

    Patients who manage type 2 diabetes with drugs that lower glucose or blood sugar may be at higher risk for heart failure. This was the finding of a comprehensive analysis of clinical trials covering more than 95,000 patients reported in The Lancet Diabetes and Endocrinology. The study was also presented at the 64th Annual Scientific Session of the American College of Cardiology in San Diego, CA, earlier this week.

  • Injured kidneys may be more viable for transplant than previously thought

    A new study led by Yale University in New Haven, CT, overturns previous thinking that injured kidneys from deceased donors are not fit for transplant. The study suggests that such kidneys may be more viable for transplant than is commonly assumed, and as there is a growing demand for organ transplants, they should be considered for use.